These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 215107)
21. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV. Fresen KO; Cho MS; zur Hausen H Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377 [TBL] [Abstract][Full Text] [Related]
22. [Study on the effect of human herpesvirus 6 on replication of Epstein-Barr virus]. Xia Q; Meng G; Ai Y Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Aug; 33(4):235-6. PubMed ID: 11717892 [TBL] [Abstract][Full Text] [Related]
23. High Epstein-Barr virus (EBV) susceptibility of both lymphoblastoid and lymphoma cell lines derived from a Japanese patient with EBV genome-positive Burkitt's lymphoma. Okano M; Aya T; Mizuno F; Takada K; Osato T Tohoku J Exp Med; 1993 Jun; 170(2):71-9. PubMed ID: 8266328 [TBL] [Abstract][Full Text] [Related]
24. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody. Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746 [TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus carried by Raji cells: a mutant in early functions? Kallin B; Klein G Intervirology; 1983; 19(1):47-51. PubMed ID: 6298144 [TBL] [Abstract][Full Text] [Related]
26. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines. Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341 [TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of Epstein-Barr virus gp350-expressing transfected human lymphoid (Raji) cell clones. Khyatti M; Patel PC; Menezes J Int J Cancer; 1991 Jun; 48(4):591-7. PubMed ID: 1646179 [TBL] [Abstract][Full Text] [Related]
29. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA. Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749 [TBL] [Abstract][Full Text] [Related]
30. Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV. Klein G; Sugden B; Leibold W; Menezes J Intervirology; 1974; 3(4):232-44. PubMed ID: 4376804 [TBL] [Abstract][Full Text] [Related]
31. Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle. Klein G; Clements G; Zeuthen J; Westman A Int J Cancer; 1976 Jun; 17(6):715-24. PubMed ID: 59708 [TBL] [Abstract][Full Text] [Related]
32. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641 [TBL] [Abstract][Full Text] [Related]
33. A simple method for the production of specific antiserum to the second nuclear antigen (EBNA-2) of Epstein-Barr virus (EBV). Dewhurst S; Volsky DJ J Immunol Methods; 1986 Mar; 87(2):283-7. PubMed ID: 3005420 [TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-induced proteins. IV. Characterization of an EBV-associated phosphopolypeptide. Mueller-Lantzsch N; Yamamoto N J Gen Virol; 1981 Aug; 55(Pt 2):333-41. PubMed ID: 6270267 [TBL] [Abstract][Full Text] [Related]
35. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen. Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635 [TBL] [Abstract][Full Text] [Related]
36. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. Nakagomi H; Dolcetti R; Bejarano MT; Pisa P; Kiessling R; Masucci MG Int J Cancer; 1994 Apr; 57(2):240-4. PubMed ID: 8157362 [TBL] [Abstract][Full Text] [Related]
37. Functional complementation between Epstein-Barr virus and herpesvirus papio. Prachová K; Roubal J; Agrba VZ; Timanovskaya VV; Voevodin AF Intervirology; 1983; 19(1):52-5. PubMed ID: 6298145 [TBL] [Abstract][Full Text] [Related]
38. Blocking of acid-fixed nuclear binding of Epstein-Barr virus nuclear antigen (EBNA) by different DNA species. Hirsch I; Kuchlerová L; Brichácek B; Suchánková A; Vonka V J Gen Virol; 1979 Sep; 44(3):849-52. PubMed ID: 231093 [TBL] [Abstract][Full Text] [Related]
39. Accumulation of Epstein-Barr virus (EBV) BMRF1 protein EA-D during latent EBV activation of Burkitt's lymphoma cell line Raji. Ohashi M; Horie K; Hoshikawa Y; Nagata K; Osaki M; Ito H; Sairenji T Microbes Infect; 2007 Feb; 9(2):150-9. PubMed ID: 17223371 [TBL] [Abstract][Full Text] [Related]
40. Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine. Hampar B; Derge JG; Martos LM; Walker JL Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3185-9. PubMed ID: 4332012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]